Search
for
Sort by
Research 661–690 of 1000+
- Emerging pharmacotherapies for Androgenetic Alopecia
- Female pattern alopecia: current perspectives
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- Princípios ativos e procedimentos na Alopecia Androgenética
- Efficacy and Safety of Laser Therapy and Phototherapy in Cicatricial and NonCicatricial Alopecia: A Systematic Review Study
- Adipose-derived stem cells applied in skin diseases, wound healing and skin defects: a review
- MICRO-URZĄDZENIA, BEZPRZEWODOWE KAPSUŁKI, MAPY, STYMULATORY I ROZRUSZNIKI STOSOWANE DO DIAGNOSTYKI I LECZENIA ZABURZEŃ MOTORYKI PRZEWODU POKARMOWEGO
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Advances in hair growth
- Cyproterone acetate for hirsutism
- Cyproterone acetate for hirsutism
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Comprehensive Overview and Treatment Update on Hair Loss
- The Roles of EDA2R in Ageing and Disease
- Update Treatment of Male Androgenetic Alopecia
- Botulinum toxin type A for the management of hidradenitis suppurativa.
- Nanotechnology-Based Strategies for Hair Follicle Regeneration in Androgenetic Alopecia
- Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis
- Female pattern hair loss: current treatment concepts.
- Revisión y avances en tricología
- Finasteride in Frontal Fibrosing Alopecia: Joining the Dots!
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Disorders of excessive hair growth in the adolescent
- Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis
- Botulinum toxin type A for the management of hidradenitis suppurativa.
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases